Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice

To test the hypothesis that myricitrin (MYR) improves type 2 diabetes, we examined the effect of MYR on hyperglycemia, glucose intolerance, hepatic steatosis, and inflammation in high-fat diet (HFD) and streptozotocin (STZ)-induced type 2 diabetic mice. Male C57BL/6J mice were randomly divided into...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Do Yeon Kim, Sang Ryong Kim, Un Ju Jung
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-03-01
Colecção:International Journal of Molecular Sciences
Assuntos:
myricitrin
diabetes
hyperglycemia
glucose intolerance
hepatic steatosis
inflammation
Acesso em linha:https://www.mdpi.com/1422-0067/21/5/1870
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados